Share Name Share Symbol Market Type Share ISIN Share Description
Cenkos Securities Plc LSE:CNKS London Ordinary Share GB00B1FLHR07 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 47.00p 45.00p 49.00p 47.90p 46.90p 47.00p 16,159 08:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 45.0 2.3 4.2 11.2 27

Cenkos Securities Share Discussion Threads

Showing 3076 to 3100 of 3450 messages
Chat Pages: Latest  126  125  124  123  122  121  120  119  118  117  116  115  Older
DateSubjectAuthorDiscuss
13/7/2018
21:01
Nice spot, tanneg. I'm going to be away for a while so nice to see someone else taking up the baton :o)
speedsgh
13/7/2018
17:08
Joint broker to this deal as well, https://www.investegate.co.uk/duke-royalty-limited--duke-/rns/fundraising-to-raise--44-million-and-notice-of-egm/201807131656146525U/ Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-standing businesses in Europe and abroad, is pleased to announce a conditional placing and subscription ("Fundraising") to raise £44 million, before expenses by way of the issue of 100,000,000 ordinary shares of no par value ("New Shares") at a price of 44 pence per share (the "Issue Price"). The net proceeds of the Fundraising of approximately £42 million will allow the Company to continue to finance its diversified pipeline of royalty financing opportunities.
tanneg
13/7/2018
07:52
Also a tiddler yesterday which I assume Cenkos will be acting on for Gusbourne (GUS) who are looking to raise £3-5m via an Offer for Subscription... Proposed fundraise - HTTPS://www.investegate.co.uk/gusbourne-plc--gus-/rns/proposed-fundraise/201807121040364579U/
speedsgh
13/7/2018
07:46
2 deals announced today! https://www.investegate.co.uk/creo-medical-group--creo-/rns/conditional-placing-of-new-ordinary-shares/201807130700035252U/ Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, today announces that it has conditionally raised, in aggregate, up to £48.5 million (before expenses) by way of three share placings by Cenkos Securities plc ("Cenkos") at the Placing Price of 125 pence per Ordinary Share. https://www.investegate.co.uk/marlowe-plc--mrl-/rns/placing-to-raise--20-million/201807130700035198U/ The Company will raise up to £20 million in gross proceeds (approximately £19 million net of expenses) through the Placing of the Placing Shares at the Issue Price through Cenkos Securities plc ("Cenkos") and Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"). The Placing Shares will be issued under the Company's existing authorities.
tanneg
03/7/2018
12:48
Not sure if Cenkos is involved in the £5m institutional placing announced yday pm by UK Oil & Gas Investments (UKOG). Cenkos are listed as joint broker to UKOG alongside WH Ireland (joint broker/Nomad) but the announcement states that the "placing is conditional upon the terms of a placing agreement with Novum and shares being admitted to trading on AIM"? Completion of £5 million Institutional Placing - HTTPS://www.investegate.co.uk/uk-oil---38--gas-inv-plc--ukog-/rns/completion-of--5-million-institutional-placing/201807021618093173T/
speedsgh
02/7/2018
08:47
UK stocks coverage shrinks after new research rules - HTTP://www.euronews.com/2018/06/29/uk-stocks-coverage-shrinks-after-new-research-rules ... London-based Cenkos, for example, now covers around 150 companies, according to a source familiar with the company, down from 170 in December and 195 at the end of 2016, according to its annual report. In March, it reported revenues from its research division fell 41 percent to 2.9 million pounds in 2017. Cenkos did not respond to requests for comment...
speedsgh
02/7/2018
08:45
Good spot re Safe Harbour IPO on 15/3 on which Cenkos (also Nomad), Numis & Macquarie Capital all acted as joint broker helping to raise £22.7m.
speedsgh
30/6/2018
08:39
3 IPO's - Safe Harbour, Rosenblatt and RA International.
topvest
30/6/2018
08:36
Looking at their transactions and what's on this BB it looks like they have raised just over £400m in H1 which is not fantastic. As always, one blockbuster deal could change things, but plenty of work to do in H2.
topvest
29/6/2018
19:57
Yes, and it didn't take much time for Hipgnossis/N+1 Singer to get the placing away either, a complete contrast to their attempt in 2017. Not sure if that is any reflection on Cenkos last time round or not but it has to now be filed in the 'ones that got away' folder. Did a bit of research this week. Plenty of primary (IPO) & secondary fundraising actvity in the market. I counted 42 IPOs announced in H1*; Cenkos involved in just 2 (Rosenblatt Group raising £43m; RA International Group raising £18.8m). Get the impression that Cenkos need to up their game as they seem to be underperforming. * 32 out the 42 IPOs announced in H1 were announced in May/Jun.
speedsgh
29/6/2018
18:53
Still missing a big deal. Hipgnosis appears to be a lost opportunity as it was over subscribed.
topvest
29/6/2018
08:01
Further to posts 2844 (topvest) & 2845 (CWA1), RA International Group have today completed their IPO, successfully raising gross proceeds of £18.8m via a placing. Cenkos is acting as nominated adviser and broker... Admission to Trading on AIM - HTTPS://www.investegate.co.uk/ra-intnl-group-plc--rai-/rns/admission-to-trading-on-aim/201806290700019628S/
speedsgh
28/6/2018
14:31
Placing of shares to raise £30 million by Stobart, https://www.investegate.co.uk/eddie-stobart--esl-/rns/acquisition-of-tpn-and-placing-of-shares/201806281214519019S/ "The Board is pleased to announce that the Company has conditionally raised gross proceeds of approximately £30 million through a placing (the "Placing") of 21,428,572 new Placing Shares at a price of 140 pence per share. The Placing has been undertaken with new and existing institutional shareholders by Cenkos Securities PLC ("Cenkos") and Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg")
tanneg
27/6/2018
13:27
A couple of Cenkos employees have been poached by Cannacord... Canaccord adds five City analysts in research push - HTTPS://www.fnlondon.com/articles/canaccord-adds-five-city-analysts-in-research-push-20180626 Canaccord Genuity has made a raft of senior hires to its bench of European and UK equity analysts, shrugging off concerns about the impact of new EU research rules on the City's smaller brokers. The Toronto-based bank has hired from rivals Liberum, Stockdale Securities and Cenkos at a time when some smaller research providers in the UK have begun to feel the full force of the EU's second Markets in Financial Instruments Directive. Mifid II, which came into force in January, requires fund managers to split out the costs of investment research from the dealing commissions they pay brokers — forcing them to become more selective about what they pay for. Justin Bates and Portia Patel are set to join Canaccord from Liberum, with Bates leading Canaccord’s financials research team in London when he takes on the role in August. Bates joined Liberum in 2014, having previously worked at Keefe, Bruyettes & Woods and Numis Securities. Patel has worked at Liberum since October 2016. She joined the firm after holding various roles at RBC Capital Markets for almost five years. Canaccord has also recruited Joanna Parsons from Stockdale Securities, where she is head of research. Prior to working at Stockdale, Parsons worked for Royal Bank of Scotland and HSBC. Alex Aylen and Bobbie Hilliam, both currently at Cenkos, will complete the raft of hires...
speedsgh
27/6/2018
11:01
Loss of mandate... Cenkos were previously acting as sponsor, financial adviser & bookrunner on the IPO of Hipgnosis Songs Fund Ltd which was first announced on 22/6/17 and was looking to raise £200m (min target £100m) - HTTPS://www.investegate.co.uk/hipgnosis-songs-fund/rns/intention-to-float/201706220900018574I/ The IPO was subsequently shelved. Hipgnosis have now announced that they intend to attempt to float again. They are again looking to raise £200m via a placing & offer for subscription. Cenkos appear to have lost out to N+1 Singer who have been appointed as Financial Adviser & Bookrunner - HTTPS://www.investegate.co.uk/hipgnosis-songs-fund/rns/intention-to-float/201806270700056809S/
speedsgh
25/6/2018
11:46
New mandate. Cenkos have been appointed sole broker to Trinity Exploration & Production (TRIN), replacing Cantor Fitzgerald Europe... Appointment of Broker - HTTPS://www.investegate.co.uk/trinity-exploration/rns/appointment-of-broker/201806250701033205S/ In a separate announcement Trinity Exploration & Production (TRIN) have announced a Placing/Subscription/Offer to raise up to $20m. Cenkos are acting as lead bookrunner alongside Whitman Howard who are acting as joint bookrunner & SPARK Advisory Partners who are acting as Nomad/Financial Adviser... $20m fundraise to accelerate growth and repay debt - HTTPS://www.investegate.co.uk/trinity-exploration/rns/-20m-fundraise-to-accelerate-growth-and-repay-debt/201806250700083203S/
speedsgh
18/6/2018
07:39
As referred to by topvest:- https://www.investegate.co.uk/ra-intnl-group-plc/rns/intention-to-float---aim/201806180700066360R/ RA International, a leading provider of services to remote locations in Africa and the Middle East, is pleased to announce its intention to seek admission of its Ordinary Shares to trading on the AIM Market of the London Stock Exchange ("Admission"). Cenkos Securities is acting as nominated adviser and sole broker to the Company in relation to Admission.
cwa1
15/6/2018
20:51
Another c£20m. http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/other/13681190.html
topvest
14/6/2018
20:07
Yes, only about £300m raised YTD so need some big deals to come through. One big one would do!
topvest
14/6/2018
14:31
Only a couple of weeks to go until end of H1. It's looking like funds raised will be somewhat less than H1 2017 which wasn't great itself (H2 2017 was much stronger). This is somewhat disappointing; there is plenty of IPO/fundraising activity going on, so the lack of activity for Cenkos is slightly concerning. The outlook statement at the AGM a month ago was more bullish than at the time of Final Results but they have plenty of catching up to do in H2 in order to match 2017 figs. Aimho
speedsgh
12/6/2018
17:15
Yesterday may have been connected with the Quindell KPMG fine possibly.
topvest
12/6/2018
16:23
No, other than to say that this share has always bounced around a lot on thin trade.
lord gnome
12/6/2018
16:16
Anyone got a clue as to what has been going on the last couple of days?
goldry
07/6/2018
07:49
A bit more work in the pipeline. Cenkos have been lined up as Nomad & joint broker to Neuroprotexeon who are planning to IPO on AIM in H2 2018... Announces Plan for Initial Public Offering on AIM - HTTPS://www.investegate.co.uk/neuroprotexeon/rns/announces-plan-for-initial-public-offering-on-aim/201806070700095761Q/ NeuroproteXeon, a late clinical-stage pharmaceutical and drug delivery device company developing and commercializing the proprietary use and delivery of XENEX™ (pharmaceutical grade xenon gas for inhalation), announces today that it is seeking to complete an initial public offering on AIM, a market operated by the London Stock Exchange during the second half of 2018. The net proceeds of the proposed capital raise will allow NPXe to complete a Phase III trial for XENEX™, in conjunction with targeted temperature management, to improve survival and functional capabilities of patients with Post-Cardiac Arrest Syndrome ("PCAS"). The first patient is expected to be treated this summer. Cenkos Securities plc ("Cenkos") is to act as Nominated adviser and joint broker to NeuroproteXeon and WG Partners LLP ("WG Partners") is to act as joint broker. Subject to prevailing market conditions and investor demand, the Company is seeking a new money valuation significantly in excess of the $59 million achieved in the last round of financing, which was completed in 2017. Since that date, and as previously announced, NPXe has entered into a licensing agreement with Linde AG (LIN.DE). Together with its existing agreement with Mallinckrodt LLC (NYSE:MNK) the combined agreements will provide NPXe with up to £44.6 million in milestone payments. Of this amount, c.£12.5 million has either already been earned or is anticipated in relation to the commencement of the Phase III study. Each license includes an increasing multi-tiered royalty structure...
speedsgh
05/6/2018
22:11
Thanks for the quick replies, will have to chase up AJ Bell tomorrow, first time they've ever been more than 1 day late with a divi for me.
isaallowance
Chat Pages: Latest  126  125  124  123  122  121  120  119  118  117  116  115  Older
Your Recent History
LSE
CNKS
Cenkos Sec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191019 19:26:15